Education
About Us
Working with TipRanks
Follow Us
Omega Therapeutics, Inc. (OMGA)
NASDAQ:OMGA
OMGA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $4.46
Previous CloseN/A
Volume114.25K
Average Volume (3M)N/A
Market Cap
$8.85M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Mar 06, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.32
Shares Outstanding55,366,215
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.09
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.00Price Target Upside2252.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Omega Therapeutics News
OMGA FAQ
What was Omega Therapeutics, Inc.’s price range in the past 12 months?
Omega Therapeutics, Inc. lowest stock price was $0.10 and its highest was $4.46 in the past 12 months.
What is Omega Therapeutics, Inc.’s market cap?
Omega Therapeutics, Inc.’s market cap is $8.85M.
When is Omega Therapeutics, Inc.’s upcoming earnings report date?
Omega Therapeutics, Inc.’s upcoming earnings report date is Mar 06, 2025 which is 149 days ago.
How were Omega Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Omega Therapeutics, Inc. overvalued?
According to Wall Street analysts Omega Therapeutics, Inc.’s price is currently Undervalued.
Does Omega Therapeutics, Inc. pay dividends?
Omega Therapeutics, Inc. does not currently pay dividends.
What is Omega Therapeutics, Inc.’s EPS estimate?
Omega Therapeutics, Inc.’s EPS estimate is -0.24.
How many shares outstanding does Omega Therapeutics, Inc. have?
Omega Therapeutics, Inc. has 55,366,215 shares outstanding.
What happened to Omega Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Omega Therapeutics, Inc.?
Currently, no hedge funds are holding shares in OMGA
Omega Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (2252.94% Upside)
$4.00 (2252.94% Upside)
Blogger Sentiment
Bullish
OMGA Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 224.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 14.6%
Last 30 Days ▲ 14.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-166.90%
Trailing 12-Months
Asset Growth
-29.88%
Trailing 12-Months
Company Description
Omega Therapeutics, Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.
Omega Therapeutics (OMGA) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Beam Therapeutics
―
Verve Therapeutics
―
Ownership Overview
1.33%
Insiders
8.42% Mutual Funds
66.34% Other Institutional Investors
21.83% Public Companies and Individual Investors